PL416198A1 - Pharmaceutical composition containing combination of hyaluronic acid and plant phytoestrogens for vaginal application - Google Patents

Pharmaceutical composition containing combination of hyaluronic acid and plant phytoestrogens for vaginal application

Info

Publication number
PL416198A1
PL416198A1 PL416198A PL41619816A PL416198A1 PL 416198 A1 PL416198 A1 PL 416198A1 PL 416198 A PL416198 A PL 416198A PL 41619816 A PL41619816 A PL 41619816A PL 416198 A1 PL416198 A1 PL 416198A1
Authority
PL
Poland
Prior art keywords
phytoestrogens
pharmaceutical composition
hyaluronic acid
plant
composition containing
Prior art date
Application number
PL416198A
Other languages
Polish (pl)
Inventor
Aneta Pakieła-Rajtkowska
Jarosław Wypych
Original Assignee
Sequoia Spółka Z Ograniczoną Odpowiedzialnością
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sequoia Spółka Z Ograniczoną Odpowiedzialnością filed Critical Sequoia Spółka Z Ograniczoną Odpowiedzialnością
Priority to PL416198A priority Critical patent/PL416198A1/en
Publication of PL416198A1 publication Critical patent/PL416198A1/en

Links

Landscapes

  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Przedmiotem zgłoszenia jest kompozycja farmaceutyczna, która zawiera połączenie kwasu hialuronowego w ilości 1 - 10 mg oraz fitoestrogenów pochodzenia sojowego w ilości 0,1 - 5 mg i/lub z czerwonej koniczyny w ilości 0,1 - 5 mg, w 5 g preparatu oraz jej zastosowanie w problemach atrofii i suchości pochwy oraz infekcji intymnych.The subject of the application is a pharmaceutical composition which contains a combination of hyaluronic acid in the amount of 1 - 10 mg and phytoestrogens of soybean origin in the amount of 0.1 - 5 mg and / or from red clover in the amount of 0.1 - 5 mg, in 5 g of the preparation and its use in problems of atrophy and vaginal dryness as well as intimate infections.

PL416198A 2016-02-19 2016-02-19 Pharmaceutical composition containing combination of hyaluronic acid and plant phytoestrogens for vaginal application PL416198A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PL416198A PL416198A1 (en) 2016-02-19 2016-02-19 Pharmaceutical composition containing combination of hyaluronic acid and plant phytoestrogens for vaginal application

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL416198A PL416198A1 (en) 2016-02-19 2016-02-19 Pharmaceutical composition containing combination of hyaluronic acid and plant phytoestrogens for vaginal application

Publications (1)

Publication Number Publication Date
PL416198A1 true PL416198A1 (en) 2017-08-28

Family

ID=59684554

Family Applications (1)

Application Number Title Priority Date Filing Date
PL416198A PL416198A1 (en) 2016-02-19 2016-02-19 Pharmaceutical composition containing combination of hyaluronic acid and plant phytoestrogens for vaginal application

Country Status (1)

Country Link
PL (1) PL416198A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019213473A1 (en) * 2018-05-04 2019-11-07 The Procter & Gamble Company Compositions and methods for treating vaginal dryness

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019213473A1 (en) * 2018-05-04 2019-11-07 The Procter & Gamble Company Compositions and methods for treating vaginal dryness
US11633452B2 (en) 2018-05-04 2023-04-25 The Procter & Gamble Company Compositions and methods for treating vaginal dryness

Similar Documents

Publication Publication Date Title
MX2020014098A (en) Heterocyclic and heteroaryl compounds for treating huntington's disease.
MX2020009957A (en) Compounds for treating huntington's disease.
MX2019014514A (en) Compounds for treating huntington's disease.
MX2020014315A (en) Heteroaryl compounds for treating huntington's disease.
PH12018501226A1 (en) Methods for treating huntingtons disease
ECSP22012826A (en) PARP1 INHIBITORS
UY37952A (en) FORMULATIONS OF AN INHIBITOR OF THE QUINASA TRK MACROCYCLIC
MX2020001525A (en) Glp-1 compositions and uses thereof.
MX2021013854A (en) Compounds for treating huntington's disease.
BR112016028288A2 (en) compound, pharmaceutical composition, methods for treating an individual with a disease or condition and for inhibiting kinase, and use of a compound.
MY189761A (en) Quinazoline derivatives used to treat hiv
MX2020006612A (en) Compound functioning as bromodomain protein inhibitor, and composition.
GEP20227396B (en) Compounds and their uses for alleviating menopause-associated symptoms
MX2020008125A (en) Compositions comprising berberine.
AR112448A1 (en) SUBSTITUTED XANTHINE DERIVATIVES
BR112021020883A2 (en) Solid forms of a glyt1 inhibitor
PH12017502319A1 (en) Injectable pharmaceutical formulations of lefamulin
EA201691792A1 (en) PHARMACEUTICAL COMPOSITIONS BASED ON VILDAGLIPTINA
BR112016013974A2 (en) COMPOUND, PHARMACEUTICAL COMPOSITION, USE OF THE PHARMACEUTICAL COMPOSITION AND USE OF THE COMPOUND
MX2019014604A (en) Nasal composition.
CR20190391A (en) Pyrazole derivatives as bromodomain inhibitors
PL416198A1 (en) Pharmaceutical composition containing combination of hyaluronic acid and plant phytoestrogens for vaginal application
BR112015030669A2 (en) LIQUID DISPERSANT COMPOSITION FOR PLASTER, ITS USE AND PRODUCTION METHOD, FLUID PLASTER PASTE AND ITS PRODUCTION METHOD
EA201992844A1 (en) NEW ORAL COMPOSITIONS BASED ON BELINOSTAT
PL416202A1 (en) Pharmaceutical composition containing combination of hyaluronic acid, plant phytoestrogens and probiotic strains of Lactobacillus genus for vaginal application